Industry

– ALPN-303 dose-dependently reduces serum galactose-deficient IgA1 (Gd-IgA1), a pivotal molecule implicated in the pathogenesis of IgA nephropathy (IgAN) – – Data further supports best-in-class profile and initiation of glomerulonephritis (GN) basket clinical trial – SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and … [Read more…]

CHICAGO–(BUSINESS WIRE)–Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the third quarter ended September 30, 2022. Third Quarter 2022 Highlights Net Income Attributable to Common Stockholders (“Attributable Net Income (Loss)”) per share of $0.00 Normalized Funds from Operations* (“Normalized FFO”) per share of $0.76, inclusive of the benefit of approximately $20 … [Read more…]

Third quarter consolidated revenue of $152 million Third quarter consolidated operating profit up over 30% year-over-year Generated $42 million of cash flow from continuing operations in the quarter CHICAGO–(BUSINESS WIRE)–$MDRX #healthIT–Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2022. Third quarter 2022 Veradigm … [Read more…]

Seven accepted poster presentations showcase our continued leadership in CAR-T cell therapy research for patients with multiple myeloma New analysis of sustained minimal residual disease (MRD) negativity from the pivotal CARTITUDE-1 study of CARVYKTI® (ciltacabtagene autoleucel, cilta-cel) in heavily pretreated adults with relapsed or refractory multiple myeloma (RRMM) First conference presentation of data from the … [Read more…]

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced financial results for the three months ended September 30, 2022. Third Quarter Financial Highlights: Third quarter 2022 revenue of $340.8 million, up 23.7%, or 28.5% in constant currency1, compared … [Read more…]

Conference Call and Webcast Scheduled for 4:30 p.m. Eastern Time BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today reported recent business highlights and third quarter 2022 financial results. “This has been a year marked by progress across our pipeline. In the third quarter, we continued to advance our clinical trials and … [Read more…]

LA JOLLA, Calif.–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today reported its third-quarter 2022 financial results. “We achieved meaningful year-over-year billable sample volume growth, but sequential growth was flat due to headwinds caused by limited commercial payer coverage,” said John Dobak, … [Read more…]

Award Recognizes Innovation in the Global Life Sciences and Biotechnology Industry BETHESDA, Md.–(BUSINESS WIRE)–Longhorn Vaccines & Diagnostics, a One Health and One World company developing vaccines and diagnostic tools for global public health and zoonosis concerns, today announced it has been named “Diagnostics Company of the Year” in the second annual BioTech Breakthrough Awards program. … [Read more…]

AI-driven, multiple protein blood test data presented at 2022 American Heart Association Scientific Sessions KIRKLAND, Wash.–(BUSINESS WIRE)–Prevencio, Inc. today announces the presentation of patient data demonstrating its Artificial Intelligence (AI)-driven HART CVE blood test is highly accurate in determining whether a person with chronic kidney disease (CKD) will have a heart attack or major adverse … [Read more…]

ATLANTA–(BUSINESS WIRE)–According to a new industry report released by the Center for Global Health Innovation (The Center) and TEConomy Partners, a global leader in research and analysis, Georgia’s life sciences industry has experienced strong and steady employment growth in recent years, outpacing even the rapidly growing national industry in its private sector industrial components and … [Read more…]